For digital health companies, packaging is not a retail shelf challenge; it is a trust challenge. The box, insert, and kit are often a patient's first tangible proof that a clinical-grade product truly is clinical grade. Winston Francois creates packaging systems that pass legal and regulatory review, withstand cold-chain or medical-device shipping, and make first use simpler rather than more confusing.
The Challenge
Packaging is handled as an operational afterthought rather than a lever for conversion and retention
Most digital health teams design the app, the clinical protocol, and the marketing site first, then hand packaging to whoever is closest to the fulfillment vendor a few weeks before launch. The result is a box that ships the product but does nothing to reduce first-use anxiety or reinforce why the patient paid for this over a free app.
Legal and regulatory reviews make each packaging choice a bottleneck lasting multiple weeks
Anything that touches a device, a diagnostic, or a prescription-adjacent product usually needs sign-off from regulatory affairs, legal, and sometimes a medical director before it can print – claims language, warning labels, IFU (instructions for use) placement, and even color-coding for dosage can all trigger review cycles.
Kits must withstand shipping and cold-chain conditions, then support at-home setup by a non-technical patient
A digital health kit is frequently the only touchpoint where a real, physical, biological sample or device changes hands outside a clinical setting – a blood draw kit, a CGM sensor, a connected device that needs pairing. If the packaging does not physically protect the contents in transit or does not walk a stressed, possibly unwell patient through setup without a support call, the company eats the cost in replacement kits, support tickets, and abandoned onboarding.
Packaging inconsistencies across DTC, employer, and payer channels weaken brand credibility
A digital health company selling the same core product through a health plan, an employer benefits portal, and a direct consumer checkout often ends up with three different packaging treatments built by three different teams at three different times, none of which look like they came from the same company. When a health system procurement team or an employer benefits lead sees inconsistent materials across channels, it reads as an operational maturity problem, not just a design one.
How We Support You
We begin by mapping every point where packaging interacts with a real person in your business – the DTC unboxing, employer-distributed kit, payer-mailed device, and clinic-provided sample bag. Each context comes with its own regulatory review process, shipping conditions, and level of patient stress at the moment of opening.
Next, we shape the packaging strategy around the structural requirements that must be resolved before any visuals are created: which claims language your regulatory status allows, what IFU and warning content is legally required and where it must appear, and which fulfillment and cold-chain constraints apply. That prevents us from designing something operations later has to quietly overrule.
Regulatory and legal review are incorporated into the design timeline from day one rather than added at the end. Drafts move through your compliance stakeholders according to a defined schedule, ensuring the box that is designed is also the box that is approved – not one that requires a redo.
We create a system rather than a one-off box: a common visual and structural language that adapts across DTC, employer, and payer channels. Procurement teams and benefits leads encounter one credible, consistent brand regardless of how they found you, while channel-specific messaging and partner co-branding remain possible when contracts demand them.
The fractional, embedded model is what separates this approach from a packaging design studio. The team designing your physical materials also understands your go-to-market strategy and regulatory limitations, keeping packaging connected to the broader growth motion.
Deliverables are made for the practical demands of this category: structural packaging tested with your real shipping method rather than presented only as a render, plus content that has completed the necessary regulatory review before going to print.
What we deliver
- Packaging system architecture across DTC, employer, and payer channels with a shared visual language
- Regulatory-review-ready copy and label design for claims, warnings, and IFU content
- Unboxing sequence design for device and diagnostic kits, built to reduce setup support tickets
- Structural packaging validated against your actual shipping and cold-chain constraints
In digital health, a box performs three roles simultaneously—marketing, onboarding, and regulatory compliance—yet most companies design it as though it performs only one.
Our Methodology
We structure digital health packaging engagements as 90-day sprints because both print production and regulatory review require meaningful lead time; forcing them into the end of the process is how launch dates slip. Phase one (weeks 1-3) covers discovery and constraint mapping. We identify every channel the packaging must support, obtain the actual claims and labeling requirements from your compliance team, and validate shipping and fulfillment conditions so structural design reflects reality rather than a generic template.
Phase two (weeks 4-8) moves design and review forward together. Structural and visual development continues while copy and label content pass through compliance stakeholders on an established cadence, allowing approval to occur during design instead of afterward. For kits requiring patient setup, this phase also includes developing and testing the unboxing sequence with real packaging prototypes, not flat mockups.
Phase three (weeks 9-12) focuses on production readiness: completing print-ready files, validating vendor specifications with your actual fulfillment partner, and conducting a final structural test shipment before committing to the full print run. Unlike a traditional packaging studio, we manage regulatory review as a planned workstream beginning on day one – not as a risk uncovered in week 10.
Our Working Process
Engagements generally begin with a 30-day discovery and constraints phase. We work directly with your regulatory, clinical, and operations stakeholders instead of relying on a secondhand brief, because packaging decisions in this category most often fail when designers never speak with the person responsible for approving IFU language. By day 60, structural prototypes should be in your hands and copy should be progressing through compliance review on a clear schedule – not waiting in an inbox.
By day 90, you should have print-ready files, a shipment that has been tested, and a documented packaging system your team can expand to additional SKUs or channels without beginning again. Throughout this period, we operate as an embedded team, holding weekly working sessions with the people responsible for fulfillment, regulatory, and brand on your side – not one kickoff followed by silence until the final reveal.
Your team must provide early access to the person with regulatory or legal sign-off authority, as well as real fulfillment and shipping specifications. Guessing about either is what leads to reprints. For physical kits, we request a sample shipment so structural packaging can be tested before a complete print run is approved.
Following launch, we remain available for channel extensions, whether that means co-branded packaging for a new employer partner or different labeling requirements for a new payer contract. This allows the system to keep pace as your distribution mix expands rather than becoming fragmented again.
- Reduced support tickets and setup abandonment from clearer unboxing sequences
- Faster regulatory sign-off cycles from compliance-integrated design workflow
- Consistent brand credibility across DTC, employer, and payer packaging
- Fewer reprints from structural packaging tested against real shipping conditions
If your digital health company needs packaging design leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does packaging design cost for a digital health company?
Project-based work for a complete packaging system usually ranges from the mid five figures into six figures, based on the number of channels and SKUs involved and the regulatory review complexity associated with your product. Redesigning one DTC box costs substantially less than creating a multi-channel kit system for consumer, employer, and payer distribution, each with distinct labeling requirements.
How long does packaging redesign take with regulatory review involved?
Expect 90 days from discovery through print-ready files when compliance review is necessary, since that review must run alongside design rather than follow it. Companies attempting to shorten the schedule often print a version that requires reprinting after legal or regulatory identifies a problem, ultimately consuming more time than incorporating review from the outset.
Will you collaborate directly with our legal and regulatory teams throughout design?
Yes. It is a mandatory part of our process, not an optional extra. Starting in week one, we establish a review cadence with the people authorized to approve claims language, IFU content, and labeling, because packaging developed without their involvement will be returned for rewriting.
What makes this different from engaging a packaging design agency?
A packaging studio typically creates an attractive box and hands it over; most are not set up to manage FDA labeling requirements, payer co-branding contracts, or the practical need for a kit to withstand cold-chain delivery to a patient's home. Our embedded team understands your regulatory boundaries, channel mix, and growth strategy, allowing packaging to reinforce your wider go-to-market efforts rather than operate apart from them.
How do you evaluate the ROI of a packaging redesign?
We measure performance using the outcomes packaging directly affects: support ticket volume caused by setup confusion, kit-related returns or churn, and reprint expenses avoided by completing regulatory review correctly the first time. For DTC products, we also measure conversion from unboxing to first use when instrumentation makes that possible, because this is when packaging has the greatest role.
Which digital health companies are the best fit for this service?
The strongest fit is a company sending a physical kit, device, or diagnostic sample to patients, employees, or health plan members – particularly when selling through multiple channels with different regulatory or co-branding needs. If your packaging was created once years ago and has since been quietly adjusted by whoever needed a change, that is often the clearest signal that it should be rebuilt as a system.
